Cell and Gene Therapy Drug Delivery Devices Market Size, Share & Trends Analysis Report By Products (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe, Pre-Filled Syringe, and Infusion Bags), Commercialized Drugs, Region, And Segment Forecasts, 2025-2034

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Cell and Gene Therapy Drug Delivery Devices Market Snapshot Chapter 4. Global Cell and Gene Therapy Drug Delivery Devices Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Industry Analysis – Porter's Five Forces Analysis 4.6. Competitive Landscape & Market Share Analysis 4.7. Major Funding Investments in Cell and Gene Therapy Industry 4.8. COVID 19 Impact Analysis Chapter 5. Market Segmentation 1: By Products Estimates & Trend Analysis 5.1. By Products & Market Share, 2024 & 2034 5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Products: 5.2.1. Subretinal Injection Cannula 5.2.2. Extension Tube 5.2.3. Intravenous Catheter 5.2.4. Sterile Insulin Syringe 5.2.5. Pre-Filled Syringe 5.2.6. Infusion Bags Chapter 6. Cell and Gene Therapy Drug Delivery Devices Market Segmentation 2: By Commercialized Drugs Estimates & Trend Analysis 6.1. By Commercialized Drugs Analysis & Market Share, 2024 & 2034 6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Commercialized Drugs: 6.2.1. Luxturna 6.2.2. Kymriah 6.2.3. Provenge 6.2.4. Zolgensma 6.2.5. Yescarta 6.2.6. Strimvelis Chapter 7. Cell and Gene Therapy Drug Delivery Devices Market Segmentation 3: Regional Estimates & Trend Analysis 7.1. North America 7.1.1. North America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Products, 2021-2034 7.1.2. North America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts By Commercialized Drugs, 2021-2034 7.1.3. North America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034 7.1.3.1. U.S. 7.1.3.2. Canada 7.2. Europe 7.2.1. Europe Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034 7.2.2. Europe Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, 2021-2034 7.2.3. Europe Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034 7.2.3.1. Germany 7.2.3.2. Poland 7.2.3.3. France 7.2.3.4. Italy 7.2.3.5. Spain 7.2.3.6. UK 7.2.3.7. Rest of Europe 7.3. Asia Pacific 7.3.1. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, 2021-2034 7.3.2. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, 2021-2034 7.3.3. Asia Pacific Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034 7.3.3.1. China 7.3.3.2. India 7.3.3.3. Japan 7.3.3.4. Australia 7.3.3.5. Rest of Asia Pacific 7.4. Latin America 7.4.1. Latin America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034 7.4.2. Latin America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, (US$ Million) 2021-2034 7.4.3. Latin America Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034 7.4.3.1. Brazil 7.4.3.2. Rest of Latin America 7.5. MEA 7.5.1. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034 7.5.2. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Products, (US$ Million) 2021-2034 7.5.3. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) By Commercialized Drugs, (US$ Million) 2021-2034 7.5.4. MEA revenue Cell and Gene Therapy Drug Delivery Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034 7.5.4.1. South Africa 7.5.4.2. Rest of MEA Chapter 8. Competitive Landscape 8.1. Major Mergers and Acquisitions/Strategic Alliances 8.2. Company Profiles 8.2.1. Amgen Inc. 8.2.2. Bausch & Lomb Incorporated. 8.2.3. Becton, Dickinson and Company 8.2.4. Bluebird bio, Inc. 8.2.5. Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.) 8.2.6. Dendreon Pharmaceuticals LLC. 8.2.7. Helixmith Co., Ltd (ViroMed Co., Ltd) 8.2.8. Human Stem Cells Institute 8.2.9. Kite Pharma, Inc. 8.2.10. Kolon TissueGene, Inc. 8.2.11. Novartis AG 8.2.12. Orchard Therapeutics plc. 8.2.13. Pfizer, Inc. 8.2.14. Renova Therapeutics 8.2.15. Spark Therapeutics, Inc. 8.2.16. uniQure N.V. 8.2.17. Vericel Corporation 8.3. List of Other Prominent Players